Shares of Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY – Get Free Report) gapped down before the market opened on Wednesday . The stock had previously closed at $36.94, but opened at $35.43. Otsuka shares last traded at $35.7150, with a volume of 939 shares changing hands.
Otsuka Trading Down 4.0%
The company has a debt-to-equity ratio of 0.05, a current ratio of 2.21 and a quick ratio of 1.65. The business’s fifty day simple moving average is $36.78 and its 200 day simple moving average is $35.17. The stock has a market cap of $38.09 billion, a price-to-earnings ratio of 14.24, a P/E/G ratio of 2.62 and a beta of 0.01.
Otsuka (OTCMKTS:OTSKY – Get Free Report) last issued its earnings results on Friday, July 31st. The company reported $0.70 earnings per share for the quarter, topping analysts’ consensus estimates of $0.51 by $0.19. Otsuka had a net margin of 15.50% and a return on equity of 12.86%. The company had revenue of $4.41 billion for the quarter, compared to analysts’ expectations of $3.95 billion. Otsuka has set its FY 2026 guidance at 2.119-2.119 EPS. On average, research analysts predict that Otsuka Holdings Co., Ltd. – Unsponsored ADR will post 2.23 EPS for the current year.
About Otsuka
Otsuka Holdings Co, Ltd. is a Japan-based healthcare and consumer products group whose businesses span pharmaceuticals, nutraceuticals and consumer health products, as well as related medical and chemical activities. The company operates primarily through subsidiaries including Otsuka Pharmaceutical Co, Ltd. and serves customers in Japan and international markets.
Otsuka’s pharmaceutical operations focus on prescription medicines in areas such as psychiatry, oncology, nephrology, cardiovascular disease and several other therapeutic fields.
Further Reading
- Five stocks we like better than Otsuka
- Qualcomm’s Discount Could Vanish If Its AI Bet Pays Off
- Micron’s AI Memory Boom Could Send Shares 100% Higher
- Apple Stock Surges After Its Biggest Product Launch in Years—Can It Last?
- The Ultimate Cyber Shield: CrowdStrike Rises Past $235
Receive News & Ratings for Otsuka Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Otsuka and related companies with MarketBeat.com's FREE daily email newsletter.
